Install
Research & Evidence
Trial design, systematic reviews, medical statistics, and guideline updates.
- 4 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Research & Evidence
Measuring Swelling Around Treated Brain Tumors May Reveal Why Some Fail Radiation Therapy
1+ hour, 9+ min ago (52+ words) A Yale-led study of 36 patients shows that tracking volumetric changes in perilesional FLAIR hyperintensity after Gamma Knife radiosurgery can help distinguish radiation necrosis from recurrent tumor in non-responding brain metastases. News Source: Nathaniel Bowman. (October 7, 2026). Measuring Swelling Around Treated Brain…...
Ask About Clinical Trials on Day One
2+ week, 8+ hour ago (533+ words) (Mitch Jelniker) - For people diagnosed with small cell lung cancer, the clinical trial conversation belongs in the very first appointment. A diagnosis of SCLC can trigger a whirlwind of appointments, tests, and decisions. But amid all that noise, there is…...
Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026
16+ hour, 47+ min ago (104+ words) Astellas stands on the forefront of healthcare change to turn innovative science into value for patients.(PRNewsFoto/Astellas Pharma Inc.) – PADCEV™ (enfortumab vedotin) plus pembrolizumab data highlight durable survival benefit in advanced bladder cancer – – VYLOY™ (zolbetuximab) research reinforces the role…...
The next era of liposomal delivery: Lessons from s-equol
4+ hour, 16+ min ago (973+ words) The following content is provided by an advertiser or created on behalf of an advertiser. It is not written by the NutraIngredients Consolidated editorial team, nor does it necessarily reflect the opinions of NutraIngredients Consolidated. Liposomes have been part of…...
Incisionless radiosurgery shows promise for severe, treatment-resistant depression: Study
1+ week, 1+ day ago (535+ words) A highly focused, incisionless form of radiation therapy significantly reduced symptoms of major depression and thoughts of suicide among patients with severe, treatment-resistant psychiatric illness in a prospective observational study. Results will be presented today at the American Society for…...
Counseling Patients on Therapies With Biological Effect but Unclear Benefit
20+ hour, 3+ min ago (186+ words) Christina A. Sheil, MD The quality of evidence also matters. Randomized trials that directly evaluate outcomes patients care about generally provide stronger evidence of clinical benefit than studies relying principally on surrogate end points.1,3 Clinicians should therefore distinguish three questions: The…...
BlackDoctor, The Largest Network of Black Healthcare Professionals In America, Announces Its New Medical Advisory Board With 8 Physicians
22+ hour, 39+ min ago (369+ words) AfroTech BlackDoctor, The Largest Network of Black Healthcare Professionals In America, Announces Its New Medical Advisory Board With 8 Physicians BlackDoctor has announced its new medical advisory board. The relaunched health and wellness platform, with the largest network of Black healthcare…...
ASCO 2023: Discussant: Quality in the Context of Quantity: Evaluating Treatment Intensification
14+ hour, 41+ min ago (491+ words) Dr. Madan first discussed the following abstract: “Patient-reported quality of life and survival outcomes: Analysis of ECOG-ACRIN E3805 chemohormonal androgen ablation randomized trial (CHAARTED) in prostate cancer”. This study demonstrated that a higher 3-month FACT-P score was associated with improved OS…...
SUO 2019: Bipolar AR Therapy
12+ hour, 25+ min ago (283+ words) SUO 2019 role of androgens in prostate cancer, use of testosterone to re-sensitize patients to hormonal therapy in castrate-resistant prostate cancer, RESTORE, TRANSFORMER Washington, DC (UroToday.com) Since Hugginsâ noble prize-winning work on the role of androgens in prostate cancer progression…...
ASCO GU 2021: Rucaparib plus Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: Pharmacokinetics and Safety Data from the Phase Ib RAMP Study
14+ hour, 36+ min ago (329+ words) ASCO GU 2021 Genitourinary Cancers Symposium Rucaparib plus Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC): Pharmacokinetics and Safety Data from the Phase Ib RAMP Study, NCT04179396, Arpit Rao (UroToday.com) Rucaparib is an inhibitor of poly (ADP-ribose) polymerase â PARP…...